Ah Han - Haw ParLtd Director
| HAWPY Stock | USD 28.64 0.00 0.00% |
Director
Mr. Han Ah Kuan is Executive NonIndependent Director of Haw Par Corporation Ltd. He joined the Group in 1991 as the General Manager of Haw Par Healthcare Limited and was appointed as a director of HPH in 1995. He was appointed to the Board on 28 January 2005 and was last reelected on 28 April 2015. He is a member of the Investment Committee. He holds a Bachelor of Business Administration degree from the University of Singapore.
| Age | 68 |
| Phone | 65 6337 9102 |
| Web | https://www.hawpar.com |
Haw ParLtd Management Efficiency
Haw ParLtd's management efficiency ratios could be used to measure how well Haw ParLtd manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Claudia Dyckerhoff | Roche Holding Ltd | 51 | |
| Anita Hauser | Roche Holding Ltd | 49 | |
| Karen Walker | Eli Lilly and | 59 | |
| Ann Fudge | Novartis AG ADR | 70 | |
| Pius Baschera | Roche Holding Ltd | 65 | |
| Katherine Baicker | Eli Lilly and | 49 | |
| Peter Wendell | Merck Company | 70 | |
| Philip Broadley | AstraZeneca PLC ADR | 52 | |
| David Hoover | Eli Lilly and | 72 | |
| Carolyn Bertozzi | Eli Lilly and | 53 | |
| Pamela Craig | Merck Company | 64 | |
| Thomas Glocer | Merck Company | 61 | |
| Michael Eskew | Eli Lilly and | 71 | |
| Eugene Washington | Johnson Johnson | 67 | |
| Robert Kidder | Merck Company | 71 | |
| Ian Davis | Johnson Johnson | 70 | |
| Ronald Williams | Johnson Johnson | 71 | |
| Marc Dunoyer | AstraZeneca PLC ADR | 72 | |
| Shriti Vadera | AstraZeneca PLC ADR | 55 | |
| Scott Davis | Johnson Johnson | 66 | |
| Marschall Runge | Eli Lilly and | 66 | |
Management Performance
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 |
Haw ParLtd Leadership Team
Elected by the shareholders, the Haw ParLtd's board of directors comprises two types of representatives: Haw ParLtd inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw ParLtd's management team and ensure that shareholders' interests are well served. Haw ParLtd's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw ParLtd's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sat Khattar, Independent Director | ||
| Siew Shiu, Acting Group Internal Audit Manager | ||
| Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
| Swee Sim, Non-Executive Independent Director | ||
| Cho Wee, Non-Executive, Non Independent Chairman of the Board | ||
| Chua Keeth, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
| Wah Ng, Deputy General Manager-Manufacturing of Healthcare | ||
| Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
| Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
| Brian Loo, Group Mang | ||
| Peter Chew, Deputy General Manager of Underwater World Singapore Pte Ltd | ||
| Kia Chew, Non-Executive Independent Director | ||
| Choon Chew, Non-Executive Independent Director | ||
| Tang Lee, Mang Communications | ||
| Tang Chow, Human Director | ||
| Anthony Chang, Curator of Underwater World Singapore Pte Ltd | ||
| Suan Lee, Non-Executive Independent Director | ||
| Kun Chiew, Group Sec | ||
| Ah Han, Executive Director, Member of Investment Committee, General Manager of Haw Par Healthcare Limited and Director of Haw Par Healthcare Limited | ||
| Hiang Gn, Non-Executive Independent Director | ||
| Seok Lim, CFO and Company Secretary | ||
| Sien Tarn, General Manager - Corporate Development & Property Division | ||
| Sung Whang, General Manager of Underwater World Pattaya Ltd | ||
| Soo Hwang, Non-Executive Independent Director | ||
| Bee Goh, Director & General Manager - Manufacturing of Haw Par Healthcare Limited | ||
| Eechao Wee, Non-Executive Non Independent Director | ||
| Say Chow, Group Finance Controller | ||
| Jasmin Hong, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
| Kay Lee, Company Secretary |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw ParLtd a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 | |||
| Profit Margin | 0.79 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (701.58 M) | |||
| Shares Outstanding | 55.34 M | |||
| Price To Earning | 21.33 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 10.01 X | |||
| Revenue | 141.18 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haw Par. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Haw Pink Sheet analysis
When running Haw ParLtd's price analysis, check to measure Haw ParLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw ParLtd is operating at the current time. Most of Haw ParLtd's value examination focuses on studying past and present price action to predict the probability of Haw ParLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw ParLtd's price. Additionally, you may evaluate how the addition of Haw ParLtd to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |